Shaoxing Xingxin New Material (001358.SZ) stock: key figures, P/E, revenue and dividend
Materials · China
Shaoxing Xingxin New Material financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 468.14 m CNY | 474.56 m CNY |
| Gross profit | 145.33 m CNY | 132.51 m CNY |
| Operating income | 93.56 m CNY | 48.48 m CNY |
| EBIT | 93.85 m CNY | 50.93 m CNY |
| Net income | 81.15 m CNY | 48.31 m CNY |
| Diluted EPS – continuing operations | 0.66 CNY | 0.39 CNY |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shaoxing Xingxin New Material
Shaoxing Xingxin New Material Co.,Ltd engages in the development of electronic and environment-friendly chemicals, pharmaceutical intermediates, high molecule materials, and other materials. The company's products include piperazine anhydrous, 2-methylpiperazine, n-methylpiperazine, n-(2-hydroxyethyl)piperazine, n,n'-di(2-hydroxyethyl)piperazine, n-(2-hydroxypropyl)-1,2-ethylenediamine, n-(2-hydroxyethyl)ethylenediamine, n,n-dimethylpropionamide, 2-methyl-1,4-diazabicyclo(2.2.2)octane, triethylene diamine, pentamethylditethylene triamine, and 2,2'-dimorpholinodiethyl ether. Shaoxing Xingxin New Material Co.,Ltd was founded in 2002 and is based in Hangzhou, China.
More stocks
- Entree Resources Ltd (ETG.TO)
- Guoanda Co Ltd (300902.SZ)
- ACACIA RESEARCH CORP (ACTG)
- Nanjing Medlander Medical Technology Co. Ltd. A (688273.SS)
- Guangdong Zhengye Technology Co Ltd (300410.SZ)
- Golden Flower Tbk PT (POLU.JK)
- Fibra Shop (FSHOP13.MX)
- Abaxx Technologies Inc (ABXX.NE)
- Changshu Tongrun Auto (603201.SS)
- Robostar Co.Ltd (090360.KQ)
- Enity (ENITY.ST)
- Cambi ASA (CAMBI.OL)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.